Drug profile · INN
besilesomab
SCINTIMUN
besilesomab (SCINTIMUN) is a diagnostic agent. Associated with Telix Innovations.
EMA: approved Various (V09) V09HA03
Patents linked 1
Pipeline programs 1
News articles 0
Drug details — besilesomab
- Class
- Various (V09)
- Route
- —
- Patents
- 1
- Programs
- 1
- Data quality
- 0.89
Quick answer
besilesomab (SCINTIMUN) is a diagnostic agent. Associated with Telix Innovations.
Key facts
INN besilesomab
Brand SCINTIMUN
Mechanism Diagnostic agent
Therapeutic class Various (V09)
ATC code V09HA03
Originator Telix Innovations
Mechanism of action
Diagnostic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is besilesomab?
besilesomab (SCINTIMUN) is a diagnostic agent. Associated with Telix Innovations.
What is the brand name for besilesomab?
SCINTIMUN is a marketed brand name for besilesomab. Check FDA Drugs@FDA for the current US label holder and prescribing information.